4.3 Article

Prognostic value of follow-up vasoreactivity test in pulmonary arterial hypertension

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Pharmacology & Pharmacy

Cyclic GMP and PKG Signaling in Heart Failure

Genri Numata et al.

Summary: The cGMP-PKG pathway plays an important role in the regulation of heart failure, and activation of this pathway has become an effective strategy for treating heart failure. However, benefits were observed only in a subgroup of patients with HFpEF, highlighting the need for further research to optimize treatment strategies.

FRONTIERS IN PHARMACOLOGY (2022)

Article Respiratory System

BMPR2 mutation status influences bronchial vascular changes in pulmonary arterial hypertension

Maria-Rosa Ghigna et al.

EUROPEAN RESPIRATORY JOURNAL (2016)

Article Critical Care Medicine

Five-Year Outcomes of Patients Enrolled in the REVEAL Registry

Harrison W. Farber et al.

Article Cardiac & Cardiovascular Systems

Residual pulmonary vasodilative reserve predicts outcome in idiopathic pulmonary hypertension

Hanno H. Leuchte et al.

Article Cardiac & Cardiovascular Systems

Prognostic value of acute vasodilator response in pulmonary arterial hypertension: Beyond the classic responders

Stephen J. Halliday et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2015)

Article Cardiac & Cardiovascular Systems

Pulmonary Arterial Hypertension The Clinical Syndrome

Yen-Chun Lai et al.

CIRCULATION RESEARCH (2014)

Article Pharmacology & Pharmacy

The Role of Nitric Oxide on Endothelial Function

Dimitris Tousoulis et al.

CURRENT VASCULAR PHARMACOLOGY (2012)

Review Cardiac & Cardiovascular Systems

Nitric oxide synthases: regulation and function

Ulrich Foerstermann et al.

EUROPEAN HEART JOURNAL (2012)

Review Cardiac & Cardiovascular Systems

Mechanisms of disease: pulmonary arterial hypertension

Ralph T. Schermuly et al.

NATURE REVIEWS CARDIOLOGY (2011)

Article Cardiac & Cardiovascular Systems

Vasoreactivity to Inhaled Nitric Oxide with Oxygen Predicts Long-Term Survival in Pulmonary Arterial Hypertension

Rajeev Malhotra et al.

Pulmonary Circulation (2011)

Review Cardiac & Cardiovascular Systems

Pulmonary vasodilator testing and use of calcium channel blockers in pulmonary arterial hypertension

Adriano R. Tonelli et al.

RESPIRATORY MEDICINE (2010)

Article Cardiac & Cardiovascular Systems

Contribution of oxidative stress to pulmonary arterial hypertension

Vincent G. DeMarco et al.

WORLD JOURNAL OF CARDIOLOGY (2010)

Review Physiology

Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure

Kurt R. Stenmark et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2009)

Article Obstetrics & Gynecology

Nitric oxide and beyond: new insights and therapies for pulmonary hypertension

R. H. Steinhorn

JOURNAL OF PERINATOLOGY (2008)

Article Cardiac & Cardiovascular Systems

Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension

O Sitbon et al.

CIRCULATION (2005)

Article Critical Care Medicine

Oxidative stress in severe pulmonary hypertension

R Bowers et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)

Article Cardiac & Cardiovascular Systems

Cellular and molecular pathobiology of pulmonary arterial hypertension

M Humbert et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)